Page last updated: 2024-10-31

midazolam and Leukoencephalopathy, Progressive Multifocal

midazolam has been researched along with Leukoencephalopathy, Progressive Multifocal in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Leukoencephalopathy, Progressive Multifocal: An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7)

Research Excerpts

ExcerptRelevanceReference
" We discuss on a clinical case requiring an exceptionally high dosage of midazolam-up to 160 mg iv daily-to achieve palliative sedation."1.40Palliative sedation for status epilepticus in a patient with progressive multifocal leukoencephalopathy. ( Cancelli, F; Dubra, A; Zulian, GB, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cancelli, F1
Dubra, A1
Zulian, GB1

Other Studies

1 other study available for midazolam and Leukoencephalopathy, Progressive Multifocal

ArticleYear
Palliative sedation for status epilepticus in a patient with progressive multifocal leukoencephalopathy.
    Journal of pain & palliative care pharmacotherapy, 2014, Volume: 28, Issue:4

    Topics: Adult; Humans; Hypnotics and Sedatives; Leukoencephalopathy, Progressive Multifocal; Male; Midazolam

2014